Abstract
Although C-reactive protein has been designated as a marker for inflammation and recently as a marker in assessment of risk in cardiovascular disorders from a number of studies across the globe, the role of CRP in other diseases have also been studied. Some of the major diseases in which CRP levels have been correlated with disease states are detailed in this chapter. Bearing a hepatic origin, C-reactive protein is a protein found in the plasma and belongs to the pentraxin family participating in the inflammatory reaction. The CRP concentration in response to injury or infection becomes escalated about 1000-fold over and above normally expressed levels. CRP is known for its function as a mediator in the classical innate immunity pathway and constitutes a part of both humoral and cellular effector systems of inflammation. Although it is well known as a marker for acute-phase response in injury of the tissue, during the infection of the host by pathogenic agents like viruses, bacteria, parasites, and inflammations, it has recently gained the status of a disease marker in cardiovascular disorders and also has been reported for its clinical and pathological significance. In this chapter we highlight the status of C-reactive protein (CRP) in different disorders and pathological conditions.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Allin KH, Nordestgaard BG, Flyger H, Bojesen SE (2011) Elevated pre-treatment levels of plasma C-reactive protein are associated with poor prognosis after breast cancer: a cohort study. Breast Cancer Res 13:R55
Ansar W, Bandyopadhyay SM, Chowdhury S, Habib SH, Mandal C (2006) Role of C-reactive protein in complement mediated hemolysis in Malaria. Glycoconj J 23(3–4):233–240
Ansar W, Habib SK, Roy S, Mandal C, Mandal C (2009a) Unraveling the C-reactive protein complement-cascade in destruction of red blood cells: potential pathological implications in Plasmodium falciparum malaria. Cell Physiol Biochem 23(1–3):175–190. doi:10.1159/000204106. Epub 2009 Feb 18
Asgari SA, Mokhtari G, Falahatkar S, Mansour-Ghanaei M, Roshani A, Zare A, Zamani M, Khosropanah I, Salehi M (2006) Diagnostic accuracy of C-reactive protein and erythrocyte sedimentation rate in patients with acute scrotum. Urol J 3(2):104–108
Autelitano DJ, Raineri L, Knight K, Bannister K, Rice GE (2012) Performance of a multianalyte test as an aid for the diagnosis of ovarian cancer in symptomatic women. J Transl Med 10:45
Bilgir O, Bilgir F, Topcuoglu T, Calan M, Calan O (2014) Comparison of high-sensitivity C-reactive protein and fetuin-A levels before and after treatment for subjects with subclinical hyperthyroidism. Endocrine 45(2):244–248
Cheng Q, Xia W, Yang S, Ye P, Mei M, Song Y, Luo M, Li Q (2013) Association of serum pigment epithelium-derived factor with high-sensitivity C-reactive protein in women with polycystic ovary syndrome. J Endocrinol Investig 36(8):632–635
Christ-Crain M, Meier C, Guglielmetti M, Huber PR, Riesen W, Staub JJ, Müller B (2003) Elevated C-reactive protein and homocysteine values: cardiovascular risk factors in hypothyroidism? A cross-sectional and a double-blind, placebo-controlled trial. Atherosclerosis 166(2):379–386
Clyne B, Olshaker JS (1999) The C-reactive protein. J Emerg Med 17:1019–1025
Czarnywojtek A, Owecki M, Zgorzalewicz-Stachowiak M, Woliński K, Szczepanek-Parulska E, Budny B, Florek E, Waligórska-Stachura J, Miechowicz I, Bączyk M, Sawicka N, Dhir S, Ruchała M (2014) The role of serum C-reactive protein measured by high-sensitive method in thyroid disease. Arch Immunol Ther Exp (Warsz) 62(6):501–509
Das UN (2001) Is obesity an inflammatory condition? Nutrition 17:953–966
Das T, Sen A, Kempf T, Pramanik SR, Mandal C, Mandal C (2003) Induction of glycosylation in human C-reactive protein under different pathological conditions. Biochem J 373(Pt 2):345–355
De Beer FC, Shine B, Pepys MB (1982a) Radiometric ligand binding assay for C-reactive protein. Complexed C reactive protein is not detectable in acute-phase serum. Clin Exp Immunol 50:231–237
Deligeoroglou E, Vrachnis N, Athanasopoulos N, Iliodromiti Z, Sifakis S, Iliodromiti S, Siristatidis C, Creatsas G (2012) Mediators of chronic inflammation in polycystic ovarian syndrome. Gynecol Endocrinol 28(12):974–978
Dobrzycka B, Mackowiak-Matejczyk B, Terlikowska KM, Kulesza-Bronczyk B, Kinalski M, Terlikowski SJ (2013) Serum levels of IL-6, IL-8 and CRP as prognostic factors in epithelial ovarian cancer. Eur Cytokine Netw 24(3):106–113
Doehn C, Fornara P, Kausch I, Büttner H, Friedrich HJ, Jocham D (2001) Value of acute-phase proteins in the differential diagnosis of acute scrotum. Eur Urol 39(2):215–221
El-Mesallamy HO, Abd El-Razek RS, El-Refaie TA (2013) Circulating high-sensitivity C-reactive protein and soluble CD40 ligand are inter-related in a cohort of women with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol 168(2):178–182
Esfahanian F, Zamani MM, Heshmat R, Moini nia F (2013) Effect of metformin compared with hypocaloric diet on serum C-reactive protein level and insulin resistance in obese and overweight women with polycystic ovary syndrome. J Obstet Gynaecol Res 39(4):806–813
Gaitonde S, Samols D, Kushner I (2008) C-reactive protein and systemic lupus erythematosus. Arthritis Rheum 59:1814–1820
Gasim S, Theander TG, ElHassan AM (2000) High levels of C-reactive protein in the peripheral blood during visceral leishmaniasis predict subsequent development of post kala-azar dermal leishmaniasis. Acta Trop 75(1):35–38
Haverkate F, Thompson SG, Pyke SDM, Gallimore JR, Pepys MB (1997) Production of C-reactive protein and risk of coronary events in stable and unstable angina. Lancet 349:462–466
Hirschfield GM, Pepys MB (2003) C-reactive protein and cardiovascular disease: new insights from an old molecule. QJM 96:793–807
Jublanc C, Bruckert E, Giral P, Chapman MJ, Leenhardt L, Carreau V, Turpin G (2004) Relationship of circulating C-reactive protein levels to thyroid status and cardiovascular risk in hyperlipidemic euthyroid subjects: low free thyroxine is associated with elevated hsCRP. Atherosclerosis 172(1):7–11
Kaya C, Akgül E, Pabuccu R (2010) C-reactive protein and homocysteine levels are associated with abnormal heart rate recovery in women with polycystic ovary syndrome. Fertil Steril 94(1):230–235
King DE, Mainous AG 3rd, Buchanan TA, Pearson WS (2003) C-reactive protein and glycemic control in adults with diabetes. Diabetes Care 26:1535–1539
Markt SC, Rider JR, Penney KL, Schumacher FR, Epstein MM, Fall K, Sesso HD, Stampfer MJ, Mucci LA (2014) Genetic variation across C-reactive protein and risk of prostate cancer. Prostate 74(10):1034–1042. doi:10.1002/pros.22820, Epub 2014 May 20
Martocchia A, Cola S, Frugoni P, Indiano I, D’Urso R, Falaschi P (2010) The burden of comorbidity and the C-reactive protein levels in nonthyroidal illness syndrome with metabolic syndrome and atherosclerosis-related cardiovascular complications. Ann N Y Acad Sci 1193:164–166
Mugabo Y, Li L, Renier G (2010) The connection between C-reactive protein (CRP) and diabetic vasculopathy. Focus on preclinical findings. Curr Diabetes Rev 6(1):27–34
Nagasaki T, Inaba M, Shirakawa K, Hiura Y, Tahara H, Kumeda Y, Ishikawa T, Ishimura E, Nishizawa Y (2007) Increased levels of C-reactive protein in hypothyroid patients and its correlation with arterial stiffness in the common carotid artery. Biomed Pharmacother 61(2–3):167–172, Epub 2007 Feb 21
Nebiker CA, Delko T, Zulewski H, Oertli D (2013) Acute thyroid swelling and elevated C reactive protein. BMJ Case Rep 2013. pii: bcr2013200427
Niizuma T, Terada K, Kosaka Y, Daimon Y, Inoue M, Ogita S, Kataoka N, Tanaka K (2004) Elevated serum C-reactive protein in mumps orchitis. Pediatr Infect Dis J 23(10):971
Nowicka MA, Fritz-Rdzanek A, Grzybowski W, Walecka I, Niemiec KT, Jakimiuk AJ (2010) C-reactive protein as the indicator of severity in ovarian hyperstimulation syndrome. Gynecol Endocrinol 26(6):399–403
Oliveira EB, Gotschlich EC, Liu T-Y (1979) Primary structure of human C-reactive protein. J Biol Chem 254(2):489–502
Orre IJ, Murison R, Dahl AA, Ueland T, Aukrust P, Fosså SD (2009) Levels of circulating interleukin-1 receptor antagonist and C-reactive protein in long-term survivors of testicular cancer with chronic cancer-related fatigue. Brain Behav Immun 23(6):868–874
Pepys MB, Hirschfield GM (2003) C-reactive protein: a critical update. J Clin Invest 111:1805–1812
Pepys MB, Gallimore JR, Lloyd J, Li Z, Graham D, Taylor GW et al (2012) Isolation and characterization of pharmaceutical grade human pentraxins, serum amyloid P component and C-reactive protein, for clinical use. J Immunol Methods 384:92–102
Piciu A, Piciu D, Marlowe RJ, Irimie A (2013) Highly-sensitive C-reactive protein, a biomarker of cardiovascular disease risk, in radically-treated differentiated thyroid carcinoma patients after repeated thyroid hormone withholding. Exp Clin Endocrinol Diabetes 121(2):102–108
Poole EM, Lee IM, Ridker PM, Buring JE, Hankinson SE, Tworoger SS (2013) A prospective study of circulating C-reactive protein, interleukin-6, and tumor necrosis factor α receptor 2 levels and risk of ovarian cancer. Am J Epidemiol 178(8):1256–1264
Rezaieyazdi Z, Sahebari M, Hatef MR, Abbasi B, Rafatpanah H, Afshari JT, Esmaily H (2011) Is there any correlation between high sensitive CRP and disease activity in systemic lupus erythematosus? Lupus 20(14):1494–1500
Sasidevi A, Vellanki P, Kunselman AR, Raja-Khan N, Dunaif A, Legro RS (2013) Familial aggregation of circulating C-reactive protein in polycystic ovary syndrome. Hum Reprod 28(3):770–776. doi:10.1093/humrep/des416. Epub 2012 Dec
Strati I, Copelovici Y, Selim G (1993) [C-reactive protein (Crp) in different clinical forms of mumps infection]. Rev Roum Virol 44(3–4):305–306
Tanigaki K, Vongpatanasin W, Barrera JA, Atochin DN, Huang PL, Bonvini E, Shaul PW, Mineo C (2012) C-reactive protein causes insulin resistance in mice through Fcγ Receptor IIB-mediated inhibition of skeletal muscle glucose delivery. Diabetes 62:721–731
Tchernof A, Nolan A, Sites CK, Ades PA, Poehlman ET (2002) Weight loss reduces C-reactive protein levels in obese postmenopausal women. Circulation 105:564–569
Ter Borg EJ, Horst G, Limburg PC, van Rijswijk MH, Kallenberg CG (1990) C-reactive protein levels during disease exacerbations and infections in systemic lupus erythematosus: a prospective longitudinal study. J Rheumatol 17:1642–1648
Thompson D, Pepys MB, Wood SP (1999) The physiological structure of human C-reactive protein and its complex with phosphocholine. Structure 7:169–177
Thurner EM, Krenn-Pilko S, Langsenlehner U, Stojakovic T, Pichler M, Gerger A, Kapp KS, Langsenlehner T (2015) The elevated C-reactive protein level is associated with poor prognosis in prostate cancer patients treated with radiotherapy. Eur J Cancer 51(5):610–619. doi:10.1016/j.ejca.2015.01.002. Epub 2015 Jan 21
Toriola AT, Grankvist K, Agborsangaya CB, Lukanova A, Lehtinen M, Surcel HM (2011) Changes in pre-diagnostic serum C-reactive protein concentrations and ovarian cancer risk: a longitudinal study. Ann Oncol 22(8):1916–1921
Trabert B, Pinto L, Hartge P, Kemp T, Black A, Sherman ME, Brinton LA, Pfeiffer RM, Shiels MS, Chaturvedi AK, Hildesheim A, Wentzensen N (2014) Pre-diagnostic serum levels of inflammation markers and risk of ovarian cancer in the prostate, lung, colorectal and ovarian cancer (PLCO) screening trial. Gynecol Oncol 135(2):297–304
Tuzcu A, Bahceci M, Gokalp D, Tuzun Y, Gunes K (2005) Subclinical hypothyroidism may be associated with elevated high-sensitive c-reactive protein (low grade inflammation) and fasting hyperinsulinemia. Endocr J 52(1):89–94
Vogt B, Führnrohr B, Müller R, Sheriff A (2007) CRP and the disposal of dying cells: consequences for systemic lupus erythematosus and rheumatoid arthritis. Autoimmunity 40:295–298
Wethal T, Haugnes HS, Kjekshus J, Småstuen MC, Ueland T, Aukrust P, Fosså SD (2010) C-reactive protein; a potential marker of second cancer and cardiovascular disease in testicular cancer survivors? Eur J Cancer 46(18):3425–3433
Yu YT, Ho CT, Hsu HS, Li CI, Davidson LE, Liu CS, Li TC, Shih CM, Lin CC, Lin WY (2013) Subclinical hypothyroidism is associated with elevated high-sensitive C-reactive protein among adult Taiwanese. Endocrine 44(3):716–722
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer India
About this chapter
Cite this chapter
Ansar, W., Ghosh, S. (2016). Pathobiological Role of CRP in Diseases: Clinical Medical Applications of CRP. In: Biology of C Reactive Protein in Health and Disease. Springer, New Delhi. https://doi.org/10.1007/978-81-322-2680-2_6
Download citation
DOI: https://doi.org/10.1007/978-81-322-2680-2_6
Published:
Publisher Name: Springer, New Delhi
Print ISBN: 978-81-322-2678-9
Online ISBN: 978-81-322-2680-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)